Catalent to build a $40M analytical services facility in North Carolina's Research Triangle
Catalent is looking to make a further commitment in the Tar Heel State — and will be expanding its presence there.
The CDMO on Tuesday announced that it will build a new biologics analytical center in Durham, NC, a city just to the west of the capital and within the research triangle, a major area for drug manufacturing and laboratory work. The new facility will offer standalone analytical development and testing for biologics including cell and gene therapies.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.